Press Releases

Soterix Medical Inc. Announces the Launch of its New transcranial Direct Current Stimulation with Limited Total Energy (tDCS-LTE) Series of Products for Non-Invasive Neuromodulation

New York City –May 31, 2013

tDCS-Limited Total Energy (tDCS-LTE) is an exclusive neuromodulation technology developed by Soterix Medical Inc. Invented at The City College of New York, tDCS-LTE is the only tDCS technology platform optimized for robust low-energy Transcranial Direct Current Stimulation. tDCS-LTE is under investigation in susceptible populations including Stroke, Pediatric, Traumatic Brain Injury, etc. tDCS-LTE is made possible through a proprietary adaptive stimulation, limiting the voltage and power required for tDCS. Soterix Medical tDCS-LTE is the only non-invasive neuromodulation technology further optimized for robust deployment in a wide variety of environments including emergency medicine, home-use, etc.
tDCS-LTE technology will be incorporated into a range of Soterix Medical neuromodulation products included the industry-standard 1x1 tDCS platform with the new Soterix Medical tDCS-LTE stimulator as well as into Soterix Medical Clinical Trials (CT) stimulators, which are the preferred choice for large and multi-center clinical trials. LTE provides further advantages for power management (e.g. device miniaturization) to support future generations of home-use systems. The technology puts tDCS in compliance with general FDA guidance on limited-output devices.
Dr. Abhishek Datta, CTO of Soterix Medical states: “Limited Total Energy is the most important advancement in tDCS stimulation technology in a decade and the first technology that specifically addresses concerns about future broad deployment in clinical centers and large trials. tDCS with LTE provides superior tolerability and reproducibility, so we expect this technology to be adopted in a range of future clinical trials. The combination of increased tolerability, increased performance, and reduced risks makes LTE the substrate for future clearance and adoption of tDCS. Technologies without LTE will simply underperform in the clinic and at home.”

CAUTION: Investigational device. Federal (or United States) law limits device to investigational use.

Media Contact Narges Ghazi
Tel: +1-888-990-8327

At Soterix Medical Inc., Engineering Serving Humanity means that we're committed to bring the most advanced medical technology into the hands of people who need it. The commitment underpins everything we do.

Latest Press Releases